X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB PFIZER UNICHEM LAB/
PFIZER
 
P/E (TTM) x 33.2 28.7 115.7% View Chart
P/BV x 3.5 4.6 76.6% View Chart
Dividend Yield % 0.5 0.7 76.5%  

Financials

 UNICHEM LAB   PFIZER
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
PFIZER
Mar-16
UNICHEM LAB/
PFIZER
5-Yr Chart
Click to enlarge
High Rs3342,724 12.3%   
Low Rs1741,611 10.8%   
Sales per share (Unadj.) Rs146.9440.9 33.3%  
Earnings per share (Unadj.) Rs11.948.7 24.4%  
Cash flow per share (Unadj.) Rs16.275.8 21.4%  
Dividends per share (Unadj.) Rs2.0015.00 13.3%  
Dividend yield (eoy) %0.80.7 113.8%  
Book value per share (Unadj.) Rs105.1462.9 22.7%  
Shares outstanding (eoy) m90.8445.75 198.6%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.74.9 35.2%   
Avg P/E ratio x21.444.5 48.0%  
P/CF ratio (eoy) x15.728.6 54.9%  
Price / Book Value ratio x2.44.7 51.6%  
Dividend payout %16.830.8 54.6%   
Avg Mkt Cap Rs m23,07399,163 23.3%   
No. of employees `0005.72.9 196.4%   
Total wages/salary Rs m2,5582,758 92.8%   
Avg. sales/employee Rs Th2,352.56,981.7 33.7%   
Avg. wages/employee Rs Th450.9954.5 47.2%   
Avg. net profit/employee Rs Th190.4771.1 24.7%   
INCOME DATA
Net Sales Rs m13,34620,170 66.2%  
Other income Rs m192857 22.4%   
Total revenues Rs m13,53821,028 64.4%   
Gross profit Rs m1,6394,310 38.0%  
Depreciation Rs m3901,239 31.5%   
Interest Rs m295 553.8%   
Profit before tax Rs m1,4123,923 36.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-3599 -35.7%   
Tax Rs m2931,794 16.3%   
Profit after tax Rs m1,0802,228 48.5%  
Gross profit margin %12.321.4 57.5%  
Effective tax rate %20.745.7 45.3%   
Net profit margin %8.111.0 73.3%  
BALANCE SHEET DATA
Current assets Rs m5,97916,299 36.7%   
Current liabilities Rs m2,4327,594 32.0%   
Net working cap to sales %26.643.2 61.6%  
Current ratio x2.52.1 114.6%  
Inventory Days Days6365 96.6%  
Debtors Days Days6026 234.5%  
Net fixed assets Rs m6,4038,622 74.3%   
Share capital Rs m182458 39.7%   
"Free" reserves Rs m9,29320,722 44.8%   
Net worth Rs m9,54821,180 45.1%   
Long term debt Rs m23025 921.6%   
Total assets Rs m12,84329,137 44.1%  
Interest coverage x50.0755.5 6.6%   
Debt to equity ratio x00 2,044.3%  
Sales to assets ratio x1.00.7 150.1%   
Return on assets %8.67.7 112.7%  
Return on equity %11.310.5 107.6%  
Return on capital %14.319.0 75.5%  
Exports to sales %29.20.1 49,114.6%   
Imports to sales %6.317.5 36.3%   
Exports (fob) Rs m3,90012 32,496.7%   
Imports (cif) Rs m8473,526 24.0%   
Fx inflow Rs m4,35652 8,434.5%   
Fx outflow Rs m1,162140 830.3%   
Net fx Rs m3,194-88 -3,616.1%   
CASH FLOW
From Operations Rs m1,1193,436 32.6%  
From Investments Rs m-853-6,991 12.2%  
From Financial Activity Rs m-334-619 54.0%  
Net Cashflow Rs m-68-4,174 1.6%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 15.1 7.5 201.3%  
FIIs % 3.0 4.9 61.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 23.7 133.8%  
Shareholders   20,176 85,207 23.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SUN PHARMA  DR. REDDYS LAB  GSK PHARMA  J.B.CHEMICALS  MERCK LTD  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Rally, IMF's GDP Prediction, and Top Stocks in Action(Pre-Open)

On Tuesday, share markets in India opened in green and ended on a positive note. The BSE Sensex closed higher by 342 points to close above 36,000 levels for the first time ever.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 23, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS